Cytotoxicity and DNA fragmentation associated with sequential gemcitabine and 5-fluoro-2'-deoxyuridine in HT-29 colon cancer cells

Clinical Cancer Research

Volumn 4, Issue 11, 1998, Pages 2811-2818

  Ren, Qianfang ^a   Kao, Vivian ^a   Grem, Jean L ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b NATIONAL NAVAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; FLOXURIDINE; GEMCITABINE; THYMIDYLATE SYNTHASE;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER INHIBITION; CELL CYCLE; COLON CANCER; CONTROLLED STUDY; DNA DAMAGE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; PRIORITY JOURNAL;

ANTIMETABOLITES, ANTINEOPLASTIC; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CELL CYCLE; COLONIC NEOPLASMS; DEOXYCYTIDINE; DNA DAMAGE; DNA FRAGMENTATION; DNA, NEOPLASM; FLOXURIDINE; HT29 CELLS; HUMANS; THYMIDYLATE SYNTHASE;

EID: 0031756707     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Heinemann, V., Hertel, L. W., Grindey, G. B., and Plunkett, W. Comparison of the cellular pharmacokinetics and toxicity of 2′,2′-difluorodeoxycytidine and 1-β-D-arabinofuranosylcytosine. Cancer Res., 48: 4024-4031, 1988.
2. Plunkett, W., Gandhi, V., Chubb, S., Nowak, B., Heinemann, V., Mineishi, S., Sen, A., Hertel, L. W., and Grindey, G. B. 2′,2′-Difluorodeoxycytidine metabolism and mechanism of action in human leukemia cells. Nucleosides Nucleotides, 8: 775-785, 1989.
3. Heinemann, V., Xu, Y. Z., Chubb, S., Sen, A., Hertel, L. W., Grindey, G. B., and Plunkett, W. Cellular elimination of 2′,2′-difluorodeoxycytidine 5′-triphosphate: a mechanism of self-potentiation. Cancer Res., 52: 533-539, 1992.
4. Heinemann, V., Xu, Y. Z., Chubb, S., Sen, A., Hertel, L. W., Grindey, G. B., and Plunkett, W. Inhibition of ribonucleotide reduction in CCRF-CEM cells by 2′,2′-difluorodeoxycytidine. Mol. Pharmacol., 38: 567-572, 1990.
5. Baker, C. H., Banzon, J., Bollinger, J. M., Stubbe, J., Samano, V., Robins, M. J., Lippert, B., Jarvi, E., and Resvick, R. 2′-Deoxy-2′-methylenecytidine and 2′-deoxy-2′,2′-difluorocytidine 5′-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase. J. Med. Chem., 34: 1879-1884, 1991.
6. Huang, P., Chubb, S., Hertel, L. W., Grindey, G. B., and Plunkett, W. Action of 2′,2′-difluorodeoxycytidine on DNA synthesis. Cancer Res., 51: 6110-6117, 1991.
7. Huang, P., Robertson, L. E., Wright, S., and Plunkett, W. High molecular weight DNA fragmentation: a critical event in nucleoside analogue-induced apoptosis in leukemia cells. Clin. Cancer Res., 1: 1005-1013, 1995.
8. Ross, D. D., and Cuddy, D. P. Molecular effects of 2′,2′-difluorodeoxycytidine (gemcitabine) on DNA replication in intact HL-60 cells. Biochem. Pharmacol., 48: 1619-1630, 1994.
9. Huang, P., and Plunkett, W. Fludarabine-and gemcitabine-induced apoptosis: incorporation of analogs into DNA is a critical event. Cancer Chemother. Pharmacol., 36: 181-188, 1995.
10. -) fragment. Cancer Res., 53: 4582-4587, 1993.
11. Thatcher, N., Hopwood, P., and Anderson, H. Improving quality of life in patients with non-small cell lung cancer: research experience with gemcitabine. Eur. J. Cancer, 33 (Suppl. 1): S8-S13, 1997.
12. Lund, B., Hansen, O. P., Theilade, K., Hansen, M., and Neijt, J. P. Phase II study of gemcitabine (2′,2′-difluorodeoxycytidine) in previously treated ovarian cancer patients. J. Natl. Cancer Inst., 86: 1530-1533, 1994.
13. Rothenberg, M. L., Moore, M. J., Cripps, M. C., Andersen, J. S., Portenoy, R. K., Burris, H. A., III, Green, M. R., Tarassoff, P. G., Brown, T. D., Casper, E. S., Storniolo, A. K., and Von Hoff, D. D. A phase II trial of gemcitabine in patients with 5-FU-refractory pancreatic cancer. Ann. Oncol., 7: 347-353, 1996.
14. Carmichael, J., Possinger, K., Phillip, P., Beykirch, M., Kerr, H., Walling, J., and Harris, A. L. Advanced breast cancer: a phase II trial with gemcitabine. J. Clin. Oncol., 13: 2731-2736, 1995.
15. Grem, J. L. Fluoropyrimidines. In: B. A. Chabner and D. L. Longo (eds.), Cancer Chemotherapy and Biotherapy: Principles and Practice, Ed. 2, pp. 149-211. Philadelphia: Lippincott-Raven Publishers, 1996.
16. Grem, J. L., and Allegra, C. J. Sequence-dependent interaction of 5-fluorouracil and arabinosyl-5-azacytosine or 1-β-D-arabinofuranosyl-cytosine. Biochem. Pharmacol., 42: 409-418, 1991.
17. Grem, J. L., and Fischer, P. H. Alteration of fluorouracil metabolism in human colon cancer cells with a selective increase in fluorodeoxyuridine monophosphate levels. Cancer Res., 46: 6191-6199, 1986.
18. Grem, J. L., Geoffroy, F., Politi, P., Cuddy, D., Ross, D. D., Nguyen, D., and Allegra, C. J. Determinants of sensitivity to 1-β-D-arabinofuranosylcytosine in human colon carcinoma cell lines. Mol. Pharmacol., 48: 305-315, 1995.
19. Sherman, P. A., and Fyfe, H. A. Enzymatic assay for deoxyribonucleotide triphosphates using synthetic oligonucleotides as template primers. Anal. Biochem., 180: 222-226, 1989.
20. Ismail, A-S. A., Van Groeningen, C. J., Hardcastle, A., Ren, Q-F., Aherne, G. W., Geoffroy, F., Allegra, C. J., and Grem, J. L. Modulation of fluorouracil cytotoxicity by interferons α and γ. Mol. Pharmacol., 53: 252-261, 1998.
21. Johnston, P. G., Drake, J. C., Trepel, J., and Allegra, C. J. Immunological quantitation of thymidylate synthase using the monoclonal antibody TS106 in 5-fluorouracil-sensitive and -resistant human cancer cell lines. Cancer Res., 52: 4306-4312, 1992.
22. Ren, Q. F., Van Groeningen, C. J., Geoffroy, F., Allegra, C. J., Johnston, P. G., and Grem, J. L. Determinants of cytotoxicity with prolonged exposure to fluorouracil in human colon cancer cells. Oncol. Res., 9: 77-88, 1997.
23. Grem, J. L., Politi, P. M., Berg, S. L., Benchekroun, N. M., Patel, M., Balis, F. M., Sinha, B. K., Dahut, W., and Allegra, C. J. Cytotoxicity, and DNA damage associated with pyrazoloacridine in MCF-7 breast cancer cells. Biochem. Pharmacol., 15: 1649-1659, 1996.
24. Anderson, H., Thatcher, N., Walling, J., and Hansen, H. A phase I study of a 24 hour infusion of gemcitabine in previously untreated patients with inoperable non-small-cell lung cancer. Br. J. Cancer, 74: 460-462, 1996.
25. 2) levels. Invest. New Drugs, 15: 115-121, 1997.
26. Yoshioka, A., Tanaka, S., Hiraoka, O., Koyama, Y., Hirota, Y., Ayusawa, D., Seno, T., Garret, C., and Wataya, Y. Deoxyribonucleoside triphosphate imbalance-fluorodeoxyuridine-induced DNA double strand breaks in mouse FM3A cells and the mechanism of cell death. J. Biol. Chem., 262: 8235-8241, 1987.
27. Houghton, J. A., Tillman, D. M., and Harwood, F. G. Ratio of 2′-deoxyadenosine-5′-triphosphate/thymidine-5′-triphosphate influences the commitment of human colon carcinoma cells to thymineless death. Clin. Cancer Res., 1: 723-730, 1995.
28. Wadler, S., Horowitz, R., Mao, X., and Schwartz, E. L. Effect of Interferon of 5-fluorouracil-induced perturbations in pools of deoxynucleotide triphosphates and DNA strand breaks. Cancer Chemother. Pharmacol., 38: 529-535, 1996.
29. Bouffard, D. Y., and Momparler, R. L. Comparison of the induction of apoptosis in human leukemic cell lines by 2′,2′-difluorodeoxycytidine (gemcitabine) and 1-β-D-arabinofuranosylcytosine. Leuk. Res., 19: 849-856, 1995.
30. Darzynkiewicz, Z. Methods in analysis of apoptosis and cell necrosis. In: J. Parker and C. Stewart (eds.), The Purdue Cytometry CD-ROM, Vol. 3. West Lafayette, IN: Purdue University, 1997.
31. Ayusawa, D., Arai, H., Wataya, Y., and Seno, T. A specialized form of chromosomal DNA degradation induced by thymidylate stress in mouse FM3A cells. Mutat. Res., 200: 221-230, 1988.
32. Canman, C. E., Tang, H. Y., Normolle, D. P., Lawrence, T. S., and Maybaum, J. Variations in patterns of DNA damage induced in human colorectal tumor cells by 5-fluorodeoxyuridine: implications for mechanisms of resistance and cytotoxicity. Proc. Natl. Acad. Sci. USA, 89: 10474-10478, 1992.
33. Oberhammer, F., Wilson, J. W., Dive, C., Morris, I. D., Walker, P. R., and Sikorska, M. Apoptotic death in epithelial cells: cleavage of DNA to 300 and/or 50 Kb fragments prior to or in the absence of internucleosomal fragmentation. EMBO J., 12: 3679-3684, 1993.
34. Chang, W. P., and Little, J. B. Delayed reproductive death in X-irradiated Chinese hamster ovary cells. Int. J. Radiol., 60: 483-496, 1991.
35. Catchpoole, D. R., and Stewart, B. W. Etoposide-induced cytotoxicity in two human T-cell leukemic lines: delayed loss of membrane permeability rather than DNA fragmentation as an indicator of programmed cell death. Cancer Res., 53: 4287-4296, 1993.